Formulation Optimization of Human Insulin Loaded Microspheres for Controlled Oral Delivery Using Response Surface Methodology

被引:8
作者
Agrawal, Gauravkumar [1 ]
Wakte, Pravin [1 ]
Shelke, Santosh [2 ]
机构
[1] Dr Babasaheb Ambedkar Marathwada Univ, Dept Chem Technol, Aurangabad 431004, Maharashtra, India
[2] Yash Inst Pharm, Dept Pharmaceut, Aurangabad 431134, Maharashtra, India
关键词
Recombinant human Insulin; w/o/w multiple emulsion; Eudragit S-100; microspheres; response surface methodology; central composite design; RELEASE;
D O I
10.2174/1871530317666170503120129
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The objectives of the present investigation were to prepare recombinant human insulin entrapped Eudragit-S100 microspheres containing protease inhibitors and to precisely analyze the outcome of different formulation variables on the microspheres properties using a response surface methodology to develop an optimized formulation with desirable features. Methods: A central composite design was employed to produce microspheres of therapeutic protein by w/o/w multiple emulsion solvent evaporation technique using Eudragit S-100 as coating material and polyvinyl alcohol as a stabilizer. The effect of formulation variables (independent variables) that is levels of Eudragit S-100 (X1), therapeutic protein (X2), volumes of inner aqueous phase (X3) and external aqueous phase (X4) on dependant variables, that are encapsulation efficiency (Y1), drug release at pH 1.2 after 2 h (Y2) and drug release at pH 7.4 after of 2 h (Y3) were evaluated. Results: The significant terms in the mathematical models were generated for each response parameter using multiple linear regression analysis and analysis of variance. All the formulation variables except the volume of external aqueous phase (X4) exerted a significant effect (P < 0.05) on drug encapsulation efficiency (Y1) whereas first two variables, namely the levels of Eudragit S-100 (X1) and therapeutic protein (X2) materialized as the determining factors which significantly influenced drug release at pH 1.2 after 2 h (Y2) and drug release at pH 7.4 after of 2 h (Y3). The formulation was numerically optimized by framing the constraints on the dependent and independent variables using the desirability approach. The experimental values for Y1 and Y2 of optimized formulation were found to be 77.65% and 3.64%, respectively which were quite closer to results suggested by software. Conclusion: The results recorded indicate that the recombinant human insulin loaded Eudragit S-100 microspheres containing aprotinin have the benefits of higher loading efficiency, pH responsive and prolonged release characteristics, which may help to carry insulin to the optimum site of absorption.
引用
收藏
页码:149 / 165
页数:17
相关论文
共 25 条
  • [1] [Anonymous], AM J DRUG DIS DEV
  • [2] Benita S., 1996, Microencapsulation: Methods and industrial application, P1
  • [3] Formulation development and optimization of sustained release matrix tablet of Itopride HCl by response surface methodology and its evaluation of release kinetics
    Bose, Anirbandeep
    Wong, Tin Wui
    Singh, Navjot
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2013, 21 (02) : 201 - 213
  • [4] Concept, strategies, and feasibility of noninvasive insulin delivery
    Cefalu, WT
    [J]. DIABETES CARE, 2004, 27 (01) : 239 - 246
  • [5] Study of Fe3O4-PLLA-PEG-PLLA magnetic microspheres based on supercritical CO2: Preparation, physicochemical characterization, and drug loading investigation
    Chen, Ai-Zheng
    Li, Li
    Wang, Shi-Bin
    Lin, Xiao-Fen
    Liu, Yuan-Gang
    Zhao, Chen
    Wang, Guang-Ya
    Zhao, Zheng
    [J]. JOURNAL OF SUPERCRITICAL FLUIDS, 2012, 67 : 139 - 148
  • [6] Absorption and efficiency of insulin after oral administration of insulin-loaded nanocapsules in diabetic rats
    Cournarie, F
    Auchere, D
    Chevenne, D
    Lacour, B
    Seiller, M
    Vauthier, C
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 242 (1-2) : 325 - 328
  • [7] Formulation development and statistical optimization of ibuprofen-loaded polymethacrylate microspheres using response surface methodology
    Das, Sanjoy Kumar
    Yuvaraja, K.
    Khanam, Jasmina
    Nanda, Arunabha
    [J]. CHEMICAL ENGINEERING RESEARCH & DESIGN, 2015, 96 : 1 - 14
  • [8] Challenges for the oral delivery of macromolecules
    Goldberg, M
    Gomez-Orellana, I
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (04) : 289 - 295
  • [9] Gupta P., 2015, Open Pharm. Sci. J, V9, P31, DOI [DOI 10.2174/1874844901502010031, 10.2174/1874844901502010031]
  • [10] Herfindal ET, 1996, TXB THERAPEUTICS DRU